64 completed, 7 unknown, 4 terminated, 3 recruiting. 83 Phase 2, 12 Phase 1, 8 Phase 3.
Follow Allergic Rhinitis: new trials by email Literature Review of Allergic Rhinitis trials Research Report on Allergic Rhinitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Environmental Exposure Unit Trial in Subjects With Ragweed-induced Allergic Rhinitis INI-2004, Placebo - Allergic Rhinitis Due to Allergens, Rhinitis Allergic | Phase 2 | Completed | Inimmune Corporation | 78 | 2026-01-19 | 2026-04-29 |
| Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma ALUTARD SQ® Felis domesticus - Allergic Rhinitis, Allergic Asthma | Phase 1 / Phase 2 | Recruiting | University of Zurich | 36 | 2025-08-20 | 2026-03-16 |
| Study of Yupingfeng Powder Treating Allergic Rhinitis (AR) Chinese Herbal Medicine granules, Placebo - Allergic Rhinitis | Phase 2 / Phase 3 | Recruiting | Chinese University of Hong Kong | 140 | 2025-03-27 | 2026-07-27 |
| Study of Stapokibart Injection in Patients With Allergic Rhinitis Stapokibart Injection, Placebo - Allergic Rhinitis | Phase 2 | Unknown | Keymed Biosciences Co.Ltd | 120 | 2024-09-30 | 2024-11-08 |
| A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR). GR1802 injection, Placebo - Allergic Rhinitis | Phase 2 | Active not recruiting | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 240 | 2024-03-24 | 2025-04-25 |
| Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract 3,000 MM09, 9,000 MM09, Placebo sublingual - Allergic Rhinitis, Allergic Asthma | Phase 2 / Phase 3 | Not yet recruiting | Inmunotek S.L. | 90 | 2023-11-01 | 2023-10-23 |
| A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis. GR1802 injection-1, GR1802 injection-2, Placebo - Allergic Rhinitis | Phase 2 | Unknown | Zheng Liu ENT | 90 | 2023-09-07 | 2023-09-11 |
| Study of CM310 in Patients With Allergic Rhinitis CM310 - Allergic Rhinitis | Phase 2 | Completed | Keymed Biosciences Co.Ltd | 100 | 2023-08-23 | 2024-11-08 |
| Viral Mucosal Reprogramming Research Grade RG-RV - Asthma, Allergic Rhinitis | Phase 2 | Recruiting | The University of Texas Medical Branch, Galveston | 75 | 2023-04-27 | 2025-01-28 |
| Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR Dust mite drops (trade name: Changdi, Zhejiang Tawu Biotechnology Co. Ltd.). - Allergic Rhinitis | Phase 2 / Phase 3 | Unknown | People's Hospital of Anshun City of Guizhou Province | 60 | 2022-12-01 | 2022-10-06 |
| A Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis Interleukin-4 receptor responders 1, Interleukin-4 receptor responders 2, Placebo - Allergic Rhinitis | Phase 2 | Completed | Beijing Tongren Hospital | 93 | 2022-08-17 | 2023-10-19 |
| Efficacy of the Anti-Bet v 1 Monoclonal Antibodies (Given Subcutaneously) to Reduce Allergic Rhinitis and Conjunctivitis Symptoms and Skin Test Reactivity Upon Exposure to Birch Allergen in Adult Participants REGN5713, REGN5714, REGN5715 - Allergic Rhinitis, Conjunctivitis | Phase 2 | Completed | Regeneron Pharmaceuticals | 217 | 2022-08-15 | 2024-11-19 |
| Safety and Efficacy Study of PA9159 Nasal Spray for the Treatment of Seasonal Allergic Rhinitis PA9159 nasal spray solution, 10 μg once daily for 14 days, PA9159 nasal spray solution, 20 μg once daily for 14 days, PA9159 nasal spray solution, 40 μg once daily for 14 days - Allergic Rhinitis | Phase 2 | Completed | Anhui Palo Alto Pharmaceuticals, Inc. | 204 | 2022-04-15 | 2023-02-01 |
| The Effects of Using Yupingfeng Powder with Variation for the Treatment of Allergic Rhinitis Yupingfeng Powder granules, Placebo - Allergic Rhinitis | Phase 2 | Completed | Prof. Lin Zhixiu | 58 | 2022-04-12 | 2024-11-07 |
| AllerPops Reduce Nasal Symptoms in Adult Volunteers With Allergic Rhinitis AllerPops - Allergic Rhinitis | Phase 2 | Completed | AllerPops Corp | 72 | 2022-04-05 | 2023-07-24 |
| Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells Olfactory mucosa-derived mesenchymal stem cells, Standard treatment of type Allergic Rhinitis according to the clinical protocols, Standard treatment of type Chronic Polypous Rhinosinusitis according to the clinical protocols - Allergic Rhinitis, Rhinosinusitis Chronic | Phase 1 / Phase 2 | Unknown | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 60 | 2022-03-01 | 2022-01-19 |
| Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract Polvac Grass+Rye, Saline 0.9% - Rhinitis, Allergic, Seasonal, Rhinitis; Allergic, With Asthma | Phase 1 / Phase 2 | Completed | University of Zurich | 60 | 2022-02-10 | 2025-05-21 |
| A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis azelastine/fluticasone 137/50 mcg nasal spray, Dymista™ - Allergic Rhinitis | Phase 2 | Completed | Synmosa Biopharma Corp. | 136 | 2020-08-20 | 2023-09-25 |
| Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis Eye Drops, Solution in Single-Dose Container - Allergic Conjunctivitis, Allergic Rhinitis | Phase 2 | Completed | Marinomed Biotech AG | 64 | 2020-08-04 | 2022-08-25 |
| Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline Minocycline Topical, Placebos - Allergic Rhinitis, Asthma | Phase 2 | Unknown | State University of New York - Downstate Medical Center | 25 | 2019-09-26 | 2021-10-14 |
Showing 20 of 83. Sign in to see all of them.
Rhinitis, Allergic (83) · Asthma (11) · Rhinitis (10) · Rhinitis, Allergic, Seasonal (9) · Hypersensitivity (7) · Conjunctivitis (2) · Conjunctivitis, Allergic (2) · Dust Mite Allergy (2) · Eczema (2) · Nasal Obstruction (2) · Rhinitis, Allergic, Perennial (2) · Sneezing (2) · Drug-Related Side Effects and Adverse Reactions (1) · Food Hypersensitivity (1) · Respiratory Sounds (1)
Hypersensitivity, Immediate (83) · Immune System Diseases (83) · Nose Diseases (83) · Otorhinolaryngologic Diseases (83) · Respiratory Hypersensitivity (83) · Respiratory Tract Diseases (83) · Hypersensitivity (76) · Rhinitis (73) · Bronchial Diseases (11) · Infections (11) · Lung Diseases (11) · Lung Diseases, Obstructive (11) · Respiratory Tract Infections (11) · Conjunctival Diseases (3) · Eye Diseases (3)
Fluticasone (3) · (5-fluoro-2-methyl-3-quinolin-2-ylmethylindo-1-yl)acetic acid (2) · Cetirizine (2) · Desensitization, Immunologic (2) · Loratadine (2) · Probiotics (2) · Serum Albumin, Human (2) · Sodium Chloride (2) · azelastine (2) · fexofenadine (2) · (4-cyclobutyl-(1,4)diazepan-1-yl)-(6-(4-fluorophenoxy)pyridin-3-yl)methanone (1) · 3-fluoro-3-(3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl)-N-(2-methylpropyl)cyclobutanecarboxamide (1) · 6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide (1) · AZD8848 (1) · Budesonide (1)
HAL Allergy (5) · Anergis (3) · Novartis Pharmaceuticals (3) · Thammasat University (3) · ALK-Abelló A/S (2) · AstraZeneca (2) · GlaxoSmithKline (2) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · Keymed Biosciences Co.Ltd (2) · Laboratorios Leti, S.L. (2) · National University Hospital, Singapore (2) · Oxagen Ltd (2) · Pfizer (2) · Regeneron Pharmaceuticals (2) · University of Zurich (2)
United States (17) · Canada (10) · Germany (10) · China (8) · Sweden (8) · Austria (6) · Poland (5) · Spain (4) · Switzerland (4) · United Kingdom (4) · Hong Kong (3) · Thailand (3) · Denmark (2) · France (2) · Lithuania (2)
Lennart Greiff, MD, PhD (3) · Dr Lynette Shek, Consultant (2) · Francois Spertini, MD (2) · Luo Zhang (2) · Zhixiu Lin, PhD (2) · Alain Didier, Pr. (1) · Albert Finn, MD (1) · Andrew M Wilson (1) · Araya Satdhabudh, MD (1) · Bertil Andersson (1) · Brad H Goodman, MD (1)
PMID 12668793, PMID 14674933, PMID 15313870, PMID 15461603, PMID 15516669, PMID 15750716, PMID 15898976, PMID 16930249, PMID 18331513, PMID 19001265, PMID 19680119, PMID 19925886, PMID 19968632, PMID 20545698, PMID 20816182, PMID 21122901, PMID 21783242, PMID 22224763, PMID 22464647, PMID 22627366, PMID 22994348, PMID 23025511, PMID 23348417, PMID 23791985, PMID 24388010, PMID 24631153, PMID 24679069, PMID 24852424, PMID 24934402, PMID 24986270, PMID 25024716, PMID 25171868, PMID 25644617, PMID 26133030, PMID 26141263, PMID 26272281, PMID 26342289, PMID 26417901, PMID 26682038, PMID 26874355, PMID 26922931, PMID 26932169, PMID 26949057, PMID 27231527, PMID 27253988, PMID 28602936, PMID 28785597, PMID 28917723, PMID 29168570, PMID 29214012
2009 (1), 2019 (1), U01AI123337 (1)